About 180 people will get MRI scans during food and money tasks through March 2027. Noom is funding the research led by neuroscientist Michael Platt.
Recap by typeshit. Full story at CBS News.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Crypto payments to Chinese vendors selling both peptides and fentanyl ingredients rose 32% to $37.3M in 2025, TRM says, with US buyers the largest identifiable source.
A look at how regulators are handling the surge in peptide use, from approved medicines like insulin and GLP-1 drugs to the wider market.
Loading…